• DOI:10.1517/14728214.2016.1146681
Corpus ID: 207484890

Target-oriented therapy: Emerging drugs for atopic dermatitis

@article{Lauffer2016TargetorientedTE,
  title={Target-oriented therapy: Emerging drugs for atopic dermatitis},
  author={F. Lauffer and J. Ring},
  journal={Expert Opinion on Emerging Drugs},
  year={2016},
  volume={21},
  pages={81 - 89}
}

• F. Lauffer, J. Ring
• Published 2016
• Medicine
• Expert Opinion on Emerging Drugs

ABSTRACT Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease with a life-time prevalence of 10 – 20% in western countries. Patients suffer from stigmatizing eczematous skin lesions, persisting itch and sleep disorders. Starting usually in early childhood the course of AD is heterogeneous. While most frequently AD disappears before adolescence, about 30% of patients show a chronic persisting course. There is an urgent need for new therapeutic options as until now… Expand